In recent studies, chemerin was also found to positively correlate with systemic inflammation biomakers (i.e. CRP, WBC count), insulin resistance, dyslipidemia and hepatic disorders in incident and maintenance HD patients34,35. Here, CRP is linked to liver disorder.